These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25512797)

  • 41. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.
    Singh H; Pollock R; Uhanova J; Kryger M; Hawkins K; Minuk GY
    Dig Dis Sci; 2005 Dec; 50(12):2338-43. PubMed ID: 16416185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
    Farrell GC; Larter CZ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis.
    Ninomiya M; Kondo Y; Shimosegawa T
    ISRN Hepatol; 2013; 2013():237870. PubMed ID: 27335818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test.
    Korkmaz H; Unler GK; Gokturk HS; Schmidt WE; Kebapcilar L
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1137-43. PubMed ID: 26049707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evolving pathophysiologic concepts in nonalcoholic steatohepatitis.
    Neuschwander-Tetri BA
    Curr Gastroenterol Rep; 2002 Feb; 4(1):31-6. PubMed ID: 11825539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
    Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
    Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nonalcoholic fatty liver disease].
    Ko JS
    Korean J Gastroenterol; 2010 Jul; 56(1):6-14. PubMed ID: 20664312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Khan FZ; Perumpail RB; Wong RJ; Ahmed A
    World J Hepatol; 2015 Aug; 7(18):2155-61. PubMed ID: 26328027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists.
    Scheen AJ; Luyckx FH
    Acta Clin Belg; 2003; 58(2):81-91. PubMed ID: 12836490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
    Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
    Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice.
    Nakano S; Katsuno K; Isaji M; Nagasawa T; Buehrer B; Walker S; Wilkison WO; Cheatham B
    J Clin Exp Hepatol; 2015 Sep; 5(3):190-8. PubMed ID: 26628836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Immune Landscape in Nonalcoholic Steatohepatitis.
    Narayanan S; Surette FA; Hahn YS
    Immune Netw; 2016 Jun; 16(3):147-58. PubMed ID: 27340383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Young Adult Patient with Nonalcoholic Steatohepatitis Developed Severe Gastroesophageal Varices Associated with Severe Obesity and Diabetes Mellitus.
    Honma Y; Sumida K; Ogino N; Kusanaga M; Minami S; Kumei S; Matsuoka H; Watanabe T; Hiura M; Abe S; Shibata M; Harada M
    Case Rep Gastroenterol; 2018; 12(2):487-496. PubMed ID: 30283282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.
    Nakagawa H
    World J Hepatol; 2015 Aug; 7(17):2110-8. PubMed ID: 26301053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice.
    Ito M; Suzuki J; Sasaki M; Watanabe K; Tsujioka S; Takahashi Y; Gomori A; Hirose H; Ishihara A; Iwaasa H; Kanatani A
    Hepatol Res; 2006 Feb; 34(2):92-8. PubMed ID: 16423558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.